Market Overview

A Peek Into The Market Before The Trading Starts

Related CSCO
Cisco Will Buy OpenDNS For Over $600 Million
Summit Research Says CyberArk's Cutting Edge Technology Is Appealing To Many Businesses, Says Cisco And IBM Would Also Have Use For CyberArk Assets, Expects Consolidation In Sector And Believes CyberArk Could Go For A Premium
Dow 30 Stock Roundup: Cisco to Acquire OpenDNS, GE Sells Europe Private Equity Biz - Analyst Blog (Zacks)
Related ITMN
What You Need to Know About the Roche-InterMune Deal
Markets Reverse Early Morning Losses; Still Lower On The Day

Pre-open movers US stock futures are slightly higher this morning. Futures for the Dow Jones Industrial Average gained 2 points to 12,764.00 and S&P 500 index futures rose 0.40 points to 1,351.00. Nasdaq 100 futures gained 5 points to 2,617.50.

A Peek Into Global Markets European markets were mixed today. The STOXX Europe 600 Index rose 0.17%, London's FTSE 100 Index gained 0.41%, French CAC 40 index dropped 0.30% and German DAX 30 index surged 0.10%.

Asian markets ended mostly higher, with Japan's Nikkei Stock Average rising 1.11%, Chinese Shanghai Composite dropping 0.34% and Australia's S&P/ASX 200 rising 0.23%. Hong Kong's Hang Seng index surged 0.53% and India's Sensex gained 0.22%.

Broker Recommendation Analysts at BMO Capital upgraded Cisco Systems (NASDAQ: CSCO) from “market perform” to “outperform.” The target price for Cisco has been raised from $20 to $21.

Cisco shares dropped 0.06% to $17.17 in after-hours trading.

Breaking news

  • InterMune (NASDAQ: ITMN) today announced that on June 19, 2012, the company completed the previously announced sale of its rights to Actimmune® (interferon gamma-1b) to Vidara Therapeutics International Limited (Vidara). To read the full news, click here.
  • Acacia Research (NASDAQ: ACTG) announced today that a subsidiary has acquired patents for x-ray powder diffraction technology. To read the full news, click here.
  • Illumina (NASDAQ: ILMN) today launched the RapidTrack Whole Genome Sequencing Service (RapidTrack WGS), a new offering in its FastTrack Sequencing Services operation that delivers a whole human genome in less than two weeks. To read the full news, click here.
  • CB&I (NYSE: CBI) announced today that it has been awarded a contract valued in excess of US$40 million by Nizhnekamskneftekhim OAO (NKNK) to provide front end engineering and design (FEED) services for a new ethylene plant. To read the full news,

Posted-In: BMO Capital US Stock FuturesNews Futures Global Pre-Market Outlook Markets


Related Articles (ACTG + CBI)

Around the Web, We're Loving...

Get Benzinga's Newsletters